<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vsp</journal-id><journal-title-group><journal-title xml:lang="ru">Вопросы современной педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Current Pediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-5527</issn><issn pub-type="epub">1682-5535</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/vsp.v21i5.2455</article-id><article-id custom-type="elpub" pub-id-type="custom">vsp-3035</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group></article-categories><title-group><article-title>Реакция по типу сывороточной болезни, ассоциированная с вирусом Эпштейна – Барр: клинический случай</article-title><trans-title-group xml:lang="en"><trans-title>Serum Sickness-Like Reaction Associated with Epstein – Barr Virus: Clinical Case</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6760-3119</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванчиков</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanchikov</surname><given-names>Vladislav V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванчиков Владислав Владимирович - врач отделения дерматологии НИИ педиатрии и охраны здоровья детей НКЦ №2 ФГБНУ РНЦХ им. акад. Б.В. Петровского.</p><p>117593, Москва, Литовский бульвар, д. 1а,  тел.: +7 (929) 840-00-02</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">awdawd22@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2252-8570</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мурашкин</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Murashkin</surname><given-names>Nikolay N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8232-8936</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Амбарчян</surname><given-names>Э. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Ambarchian</surname><given-names>Eduard T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3003-9398</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьминова</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzminova</surname><given-names>Anastasia D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ педиатрии и охраны здоровья детей НКЦ №2 ФГБНУ РНЦХ им. акад. Б.В. Петровского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pediatrics and Child Health Research Institute in Petrovsky National Research Centre of Surgery</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НМИЦ здоровья детей; ЦГМА Управления делами Президента РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children’s Health; Central State Medical Academy of Department of Presidential Affairs</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>08</day><month>11</month><year>2022</year></pub-date><volume>21</volume><issue>5</issue><fpage>391</fpage><lpage>399</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Иванчиков В.В., Мурашкин Н.Н., Амбарчян Э.Т., Кузьминова А.Д., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Иванчиков В.В., Мурашкин Н.Н., Амбарчян Э.Т., Кузьминова А.Д.</copyright-holder><copyright-holder xml:lang="en">Ivanchikov V.V., Murashkin N.N., Ambarchian E.T., Kuzminova A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vsp.spr-journal.ru/jour/article/view/3035">https://vsp.spr-journal.ru/jour/article/view/3035</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Кольцевидные дерматозы — группа заболеваний, основным клиническим проявлением которых являются высыпания соответствующей формы. Данный паттерн проявлений обусловливает сложности в постановке диагноза. Представлен пример редко диагностируемого кольцевидного дерматоза — реакции по типу сывороточной болезни, более известной как SSLR (serum sikness-like reactions), триггером которой была инфекция вируса Эпштейна – Барр (ВЭБ).</p><p>Описание клинического случая. За 3 нед до госпитализации пациентка Д., 8 лет, отметила появление болей в животе, в дальнейшем — многочисленных полиморфных высыпаний (эритематозные пятна, уртикарные элементы), припухлости и боли в суставах, лихорадки. Самостоятельное лечение нестероидным противовоспалительным и системным антигистаминным препаратами к улучшению не привело. Пациентка была госпитализирована в педиатрическое отделение по месту жительства, где на основании результатов физикального, лабораторных (двукратное повышение активности АЛТ и АСТ, увеличение СОЭ до 166 мм/ч, обнаружение IgM к ВЭБ) и ультразвукового исследований (увеличение мезентериальных лимфатических узлов) был установлен диагноз «геморрагический васкулит Шенлейна – Геноха, смешанная форма». На фоне терапии системными глюкокортикостероидами отмечено улучшение, однако через несколько дней после завершения терапии возник рецидив высыпаний и артралгий, что послужило поводом для обращения в консультативно-диагностический центр. На момент осмотра общее состояние пациентки удовлетворительное. На коже лица, туловища и конечностей многочисленные эритематозные кольцевидные уртикарные и макулярные элементы диаметром от 3 до 12 см. В центре некоторых очагов, а также на месте разрешившихся высыпаний — синюшные пятна с нечеткими границами, которые исчезали при надавливании. Слизистые оболочки не поражены, ногти и волосы интактны. Субъективно — легкое жжение в области высыпаний, при пальпации — низкоинтенсивные болевые ощущения в левом лучезапястном суставе. В крови: повышение концентрации С-реактивного белка до 12 мг/л, увеличение СОЭ до 26 мм/ч, повышение титра IgG к ВЭБ до 47,7.</p></sec><sec><title>Заключение</title><p>Заключение. При выявлении у пациентов детского возраста кольцевидных высыпаний в сочетании с артралгиями и/или артритом, лихорадкой, наличием в анамнезе употребления лекарственных препаратов (чаще всего бета-лактамные антибиотики), недавней вакцинации или проявлений вирусной инфекции при проведении дифференциальной диагностики необходимо учитывать возможность развития SSLR, особенно если после разрешения высыпаний сохраняются застойные синюшные пятна, а лабораторные показатели неспецифичны.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Annular dermatoses are a group of diseases with major clinical manifestation of rashes of relevant form. This manifestation pattern causes difficulties in diagnosis. The case of rarely diagnosed annular dermatosis is presented: serum siknesslike reaction (SSLR) triggered by the Epstein – Barr virus (EBV).</p><p>Clinical case description. Patient D., 8 years old girl, noted abdominal pain 3 weeks before hospitalization, and later numerous polymorphic rashes (erythematous macules, urticarial elements), swelling and pain in joints. Self-treatment with non-steroidal anti-inflammatory and systemic antihistamines did not lead to any improvement. The patient was hospitalized in the pediatric department at the place of residence, where the diagnosis “Henoch-Schonlein purpura, mixed type” was established according to the results of physical, laboratory (double increase of ALT and AST, ESR up to 166 mm/h, IgM to EBV), and ultrasound (mesenteric lymph nodes hyperplasia) studies. Systemic glucocorticosteroids have led to improvement, however, few days after the end of the treatment there was relapse of rash and arthralgia. Thus, the girl was administrated to clinical diagnostic center. Patient’s general condition was satisfactory at the time of examination. There were numerous erythematous annular urticarial and macular elements (3–12 cm) on the skin of face, body and limbs. Some foci, as well as some resolved rashes had blue spots with indistinct boundaries that disappeared after compression. Mucous membranes, nails and hair were intact. Subjective symptoms — slight burning around rashes, at palpation — low-intensity pain in the left radiocarpal joint. Blood tests: C-reactive protein concentration increased up to 12 mg/L, ESR up to 26 mm/h, IgG to EBV up to 47.7.</p></sec><sec><title>Conclusion</title><p>Conclusion. During differential diagnosis we should consider the possibility of SSLR development in all pediatric patients with annular rashes associated with arthralgia and/or arthritis, fever, history of drug use (most often beta-lactam antibiotics), recent vaccination or manifestations of viral infection, especially in case of cyanotic spots after rashes resolution and non-specific laboratory parameters.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>сывороточная болезнь</kwd><kwd>SSLR</kwd><kwd>кольцевидные высыпания</kwd><kwd>кольцевидный дерматоз</kwd><kwd>реакция по типу сывороточной болезни</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>serum sickness</kwd><kwd>SSLR</kwd><kwd>annular rash</kwd><kwd>annular dermatosis</kwd><kwd>serum sickness-like reaction</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Не указан</funding-statement><funding-statement xml:lang="en">Not specified</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Todd PS, Orlowski T, Schumacher-Kim W. A Review of Annular Eruptions in Children. Pediatr Ann. 2015;44(8):e199–e204. doi: https://doi.org/10.3928/00904481-20150812-09</mixed-citation><mixed-citation xml:lang="en">Todd PS, Orlowski T, Schumacher-Kim W. A Review of Annular Eruptions in Children. Pediatr Ann. 2015;44(8):e199–e204. doi: https://doi.org/10.3928/00904481-20150812-09</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Delli Colli L, Gabrielli S, Abrams EM, et al. Differentiating Between β-Lactam-Induced Serum Sickness-Like Reactions and Viral Exanthem in Children Using a Graded Oral Challenge. J Allergy Clin Immunol Pract. 2021;9(2):916–921. doi: https://doi.org/10.1016/j.jaip.2020.08.047</mixed-citation><mixed-citation xml:lang="en">Delli Colli L, Gabrielli S, Abrams EM, et al. Differentiating Between β-Lactam-Induced Serum Sickness-Like Reactions and Viral Exanthem in Children Using a Graded Oral Challenge. J Allergy Clin Immunol Pract. 2021;9(2):916–921. doi: https://doi.org/10.1016/j.jaip.2020.08.047</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Del Pozzo-Magaña BR, Abuzgaia A, Murray B, et al. Paediatric serum sickness-like reaction: A 10-year retrospective cohort study. Paediatr Child Health. 2021;26(7):428–435. doi: https://doi.org/10.1093/pch/pxab003</mixed-citation><mixed-citation xml:lang="en">Del Pozzo-Magaña BR, Abuzgaia A, Murray B, et al. Paediatric serum sickness-like reaction: A 10-year retrospective cohort study. Paediatr Child Health. 2021;26(7):428–435. doi: https://doi.org/10.1093/pch/pxab003</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chiong FJ, Loewenthal M, Boyle M, Attia J. Serum sickness-like reaction after influenza vaccination. BMJ Case Rep. 2015;2015: bcr2015211917. doi: https://doi.org/10.1136/bcr-2015-211917</mixed-citation><mixed-citation xml:lang="en">Chiong FJ, Loewenthal M, Boyle M, Attia J. Serum sickness-like reaction after influenza vaccination. BMJ Case Rep. 2015;2015: bcr2015211917. doi: https://doi.org/10.1136/bcr-2015-211917</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta R, Fakunle I, Samji V, Hale EB. Serum Sickness-Like Reaction Associated With Acute Hepatitis B in a Previously Vaccinated Adult Male. Cureus. 2021;13(4):e14742. doi: https://doi.org/10.7759/cureus.14742</mixed-citation><mixed-citation xml:lang="en">Gupta R, Fakunle I, Samji V, Hale EB. Serum Sickness-Like Reaction Associated With Acute Hepatitis B in a Previously Vaccinated Adult Male. Cureus. 2021;13(4):e14742. doi: https://doi.org/10.7759/cureus.14742</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">McNamara K, Hughes OB, Strowd LC. Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus. Clin Dermatol. 2020;38(6):641–647. doi: https://doi.org/10.1016/j.clindermatol.2020.06.013</mixed-citation><mixed-citation xml:lang="en">McNamara K, Hughes OB, Strowd LC. Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus. Clin Dermatol. 2020;38(6):641–647. doi: https://doi.org/10.1016/j.clindermatol.2020.06.013</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mathes EF, Gilliam AE. A four-year-old boy with fever, rash, and arthritis. Semin Cutan Med Surg. 2007;26(3):179–187. doi: https://doi.org/10.1016/j.sder.2007.09.001</mixed-citation><mixed-citation xml:lang="en">Mathes EF, Gilliam AE. A four-year-old boy with fever, rash, and arthritis. Semin Cutan Med Surg. 2007;26(3):179–187. doi: https://doi.org/10.1016/j.sder.2007.09.001</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Galvão Dos Santos de Araujo AC, Moura de Almeida L, Moura de Almeida AP, et al. Serum Sickness-Like Reaction: DrugInduced Cutaneous Disease in a Child. Dermatol Pract Concept. 2021;11(3):e2021029. doi: https://doi.org/10.5826/dpc.1103a29</mixed-citation><mixed-citation xml:lang="en">Galvão Dos Santos de Araujo AC, Moura de Almeida L, Moura de Almeida AP, et al. Serum Sickness-Like Reaction: DrugInduced Cutaneous Disease in a Child. Dermatol Pract Concept. 2021;11(3):e2021029. doi: https://doi.org/10.5826/dpc.1103a29</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ali S, Corcea SL, Cristian RM, Bumbacea RS. A rapid desensitization protocol in a case of drotaverine-induced serum sickness-like reaction in a pregnant woman: A case report. Exp Ther Med. 2019;18(6):5105–5107. doi: https://doi.org/10.3892/etm.2019.8170</mixed-citation><mixed-citation xml:lang="en">Ali S, Corcea SL, Cristian RM, Bumbacea RS. A rapid desensitization protocol in a case of drotaverine-induced serum sickness-like reaction in a pregnant woman: A case report. Exp Ther Med. 2019;18(6):5105–5107. doi: https://doi.org/10.3892/etm.2019.8170</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">De Schryver S NE, Ben-Shoshan M. Severe serum sicknesslike reaction: Challenges in diagnosis and management. J C Exp Dermatol Res. 2015;6(3):1000279. doi: https://doi.org/10.4172/2155-9554.1000279</mixed-citation><mixed-citation xml:lang="en">De Schryver S NE, Ben-Shoshan M. Severe serum sicknesslike reaction: Challenges in diagnosis and management. J C Exp Dermatol Res. 2015;6(3):1000279. doi: https://doi.org/10.4172/2155-9554.1000279</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Milstien JB, Gross TP, Kuritsky JN. Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: An analysis after 1 year of marketing. Pediatrics. 1987;80(2):270–274.</mixed-citation><mixed-citation xml:lang="en">Milstien JB, Gross TP, Kuritsky JN. Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: An analysis after 1 year of marketing. Pediatrics. 1987;80(2):270–274.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lindberg MR, Todd SP, Bunker DR, DeKlotz CMC. IxekizumabInduced Serum Sickness (Like Reaction): An Unusual Adverse Effect. J Clin Rheumatol. 2021;27(8S):S469–S470. doi: https://doi.org/10.1097/RHU.0000000000001222</mixed-citation><mixed-citation xml:lang="en">Lindberg MR, Todd SP, Bunker DR, DeKlotz CMC. IxekizumabInduced Serum Sickness (Like Reaction): An Unusual Adverse Effect. J Clin Rheumatol. 2021;27(8S):S469–S470. doi: https://doi.org/10.1097/RHU.0000000000001222</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rixe N, Tavarez MM. Serum Sickness. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.</mixed-citation><mixed-citation xml:lang="en">Rixe N, Tavarez MM. Serum Sickness. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yerushalmi J, Zvulunov A, Halevy S. Serum sickness-like reactions. Cutis. 2002;69(5):395–397.</mixed-citation><mixed-citation xml:lang="en">Yerushalmi J, Zvulunov A, Halevy S. Serum sickness-like reactions. Cutis. 2002;69(5):395–397.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yorulmaz A, Akın F, Sert A, et al. Demographic and clinical characteristics of patients with serum sickness-like reaction. Clin Rheumatol. 2018;37(5):1389–1394.</mixed-citation><mixed-citation xml:lang="en">Yorulmaz A, Akın F, Sert A, et al. Demographic and clinical characteristics of patients with serum sickness-like reaction. Clin Rheumatol. 2018;37(5):1389–1394.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mathur AN, Mathes EF. Urticaria mimickers in children. Dermatol Ther. 2013;26(6):467–475. doi: https://doi.org/10.1111/dth.12103</mixed-citation><mixed-citation xml:lang="en">Mathur AN, Mathes EF. Urticaria mimickers in children. Dermatol Ther. 2013;26(6):467–475. doi: https://doi.org/10.1111/dth.12103</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Elzagallaai AA, Loubani E, Del Pozzo-Magaña BR, Rieder MJ. Pathogenesis of Beta-lactam-induced serum sickness-like reaction: The potential role of reactive drug metabolites. In: Authorea. April 07, 2020. doi: https://doi.org/10.22541/au.158629966.69248955</mixed-citation><mixed-citation xml:lang="en">Elzagallaai AA, Loubani E, Del Pozzo-Magaña BR, Rieder MJ. Pathogenesis of Beta-lactam-induced serum sickness-like reaction: The potential role of reactive drug metabolites. In: Authorea. April 07, 2020. doi: https://doi.org/10.22541/au.158629966.69248955</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Shiari R, Eshgh FA, Rowshanzamir E, Derakhshanfar H. Clinical and laboratory profile of serum sickness-like reaction in children. Indian J Rheumatol. 2011;6(4):173–177. doi: https://doi.org/10.1016/S0973-3698(11)60203-3</mixed-citation><mixed-citation xml:lang="en">Shiari R, Eshgh FA, Rowshanzamir E, Derakhshanfar H. Clinical and laboratory profile of serum sickness-like reaction in children. Indian J Rheumatol. 2011;6(4):173–177. doi: https://doi.org/10.1016/S0973-3698(11)60203-3</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Leung AKC, Leong KF, Lam JM. Acute Hemorrhagic Edema of Infancy: A Diagnostic Challenge for the General Pediatrician. Curr Pediatr Rev. 2020;16(4):285–293. doi: https://doi.org/10.2174/1573396316666200727145039</mixed-citation><mixed-citation xml:lang="en">Leung AKC, Leong KF, Lam JM. Acute Hemorrhagic Edema of Infancy: A Diagnostic Challenge for the General Pediatrician. Curr Pediatr Rev. 2020;16(4):285–293. doi: https://doi.org/10.2174/1573396316666200727145039</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Medovic R, Medovic M, Igrutinovic Z, et al. Acute hemorrhagic edema of infancy — is it really a mild, benign disease? Turk J Pediatr. 2021;63(1):141–148. doi: https://doi.org/10.24953/turkjped.2021.01.017</mixed-citation><mixed-citation xml:lang="en">Medovic R, Medovic M, Igrutinovic Z, et al. Acute hemorrhagic edema of infancy — is it really a mild, benign disease? Turk J Pediatr. 2021;63(1):141–148. doi: https://doi.org/10.24953/turkjped.2021.01.017</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Reamy BV, Servey JT, Williams PM. Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review. Am Fam Physician. 2020;102(4):229–233.</mixed-citation><mixed-citation xml:lang="en">Reamy BV, Servey JT, Williams PM. Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review. Am Fam Physician. 2020;102(4):229–233.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ozen S, Marks SD, Brogan P, et al. European consensusbased recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019;58(9):1607–1616. doi: https://doi.org/10.1093/rheumatology/kez041</mixed-citation><mixed-citation xml:lang="en">Ozen S, Marks SD, Brogan P, et al. European consensusbased recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019;58(9):1607–1616. doi: https://doi.org/10.1093/rheumatology/kez041</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gohari A, Matsell DG, Mammen C, Goldman RD. HenochSchönlein purpura in children: Use of corticosteroids for prevention and treatment of renal disease. Can Fam Physician. 2020;66(12): 895–897. doi: https://doi.org/10.46747/cfp.6612895</mixed-citation><mixed-citation xml:lang="en">Gohari A, Matsell DG, Mammen C, Goldman RD. HenochSchönlein purpura in children: Use of corticosteroids for prevention and treatment of renal disease. Can Fam Physician. 2020;66(12): 895–897. doi: https://doi.org/10.46747/cfp.6612895</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Song Y, Huang X, Yu G, et al. Pathogenesis of IgA Vasculitis: An Up-To-Date Review. Front Immunol. 2021;12:771619. doi: https://doi.org/10.3389/fimmu.2021.771619</mixed-citation><mixed-citation xml:lang="en">Song Y, Huang X, Yu G, et al. Pathogenesis of IgA Vasculitis: An Up-To-Date Review. Front Immunol. 2021;12:771619. doi: https://doi.org/10.3389/fimmu.2021.771619</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Frumholtz L, Laurent-Roussel S, Lipsker D, Terrier B. Cutaneous Vasculitis: Review on Diagnosis and Clinicopathologic Correlations. Clin Rev Allergy Immunol. 2021;61(2):181–193. doi: https://doi.org/10.1007/s12016-020-08788-4</mixed-citation><mixed-citation xml:lang="en">Frumholtz L, Laurent-Roussel S, Lipsker D, Terrier B. Cutaneous Vasculitis: Review on Diagnosis and Clinicopathologic Correlations. Clin Rev Allergy Immunol. 2021;61(2):181–193. doi: https://doi.org/10.1007/s12016-020-08788-4</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mohta A, Mehta RD, Ghiya BC. Multisystem Inflammatory Syndrome in Children Related to COVID-19 With Urticarial Vasculitis — A Double Whammy! Indian Pediatr. 2021;58(9): 894–895. doi: https://doi.org/10.1007/s13312-021-2317-0</mixed-citation><mixed-citation xml:lang="en">Mohta A, Mehta RD, Ghiya BC. Multisystem Inflammatory Syndrome in Children Related to COVID-19 With Urticarial Vasculitis — A Double Whammy! Indian Pediatr. 2021;58(9): 894–895. doi: https://doi.org/10.1007/s13312-021-2317-0</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Иванчиков В.В., Амбарчян Э.Т., Кузьминова А.Д. Дерматологические проявления COVID-19 у детей // Педиатрическая фармакология. — 2022. — Т. 19. — № 2. — С. 105–114. — doi: https://doi.org/10.15690/pf.v19i2.2398</mixed-citation><mixed-citation xml:lang="en">Ivanchikov VV, Ambarchian ET, Kuzminova AD. COVID-19 Dermatological Manifestations in Children. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2022;19(2):105–114. (In Russ). doi: https://doi.org/10.15690/pf.v19i2.2398</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Heras MO, Sancho MI, Munoz NP, Millet PU. Eosinophilic annular erythema in adults: report of two cases and review of literature. An Bras Dermatol. 2017;92(5 Suppl 1):65–68. doi: https://doi.org/10.1590/abd1806-4841.20176373</mixed-citation><mixed-citation xml:lang="en">Heras MO, Sancho MI, Munoz NP, Millet PU. Eosinophilic annular erythema in adults: report of two cases and review of literature. An Bras Dermatol. 2017;92(5 Suppl 1):65–68. doi: https://doi.org/10.1590/abd1806-4841.20176373</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lee HS, Yang JY, Kim YC. Eosinophilic annular erythema localized to the palms and the soles. Ann Dermatol. 2016;28(6):769–771. doi: https://doi.org/10.5021/ad.2016.28.6.769</mixed-citation><mixed-citation xml:lang="en">Lee HS, Yang JY, Kim YC. Eosinophilic annular erythema localized to the palms and the soles. Ann Dermatol. 2016;28(6):769–771. doi: https://doi.org/10.5021/ad.2016.28.6.769</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon S, Robinson S, Abudu M, et al. Eosinophilic annular erythema treated with dupilumab. Pediatr Dermatol. 2018;35(4): e255–e256. doi: https://doi.org/10.1111/pde.13533</mixed-citation><mixed-citation xml:lang="en">Gordon S, Robinson S, Abudu M, et al. Eosinophilic annular erythema treated with dupilumab. Pediatr Dermatol. 2018;35(4): e255–e256. doi: https://doi.org/10.1111/pde.13533</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Dacy N, Oney K, Fiala K, Parekh P. Eosinophilic annular erythema. Proc (Bayl Univ Med Cent). 2021;34(5):606–607. doi: https://doi.org/10.1080/08998280.2021.1922253</mixed-citation><mixed-citation xml:lang="en">Dacy N, Oney K, Fiala K, Parekh P. Eosinophilic annular erythema. Proc (Bayl Univ Med Cent). 2021;34(5):606–607. doi: https://doi.org/10.1080/08998280.2021.1922253</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Torrelo A, Andina D, Santonja C, et al. Erythema multiformelike lesions in children and COVID-19. Pediatr Dermatol. 2020; 37(3):442–446. doi: https://doi.org/10.1111/pde.14246</mixed-citation><mixed-citation xml:lang="en">Torrelo A, Andina D, Santonja C, et al. Erythema multiformelike lesions in children and COVID-19. Pediatr Dermatol. 2020; 37(3):442–446. doi: https://doi.org/10.1111/pde.14246</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Trayes KP, Love G, Studdiford JS. Erythema Multiforme: Recognition and Management. Am Fam Physician. 2019;100(2):82–88.</mixed-citation><mixed-citation xml:lang="en">Trayes KP, Love G, Studdiford JS. Erythema Multiforme: Recognition and Management. Am Fam Physician. 2019;100(2):82–88.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
